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Abstract
Background: Excessive and inappropriate use of antibiotics is considered to be the most important reason for 
development of bacterial resistance to antibiotics. As antibiotic resistance may spread across borders, high prevalence 
countries may serve as a source of bacterial resistance for countries with a low prevalence. Therefore, bacterial 
resistance is an important issue with a potential serious impact on all countries.
The majority of respiratory tract infections (RTIs) are treated in general practice. Most infections are caused by virus
and antibiotics are therefore unlikely to have any clinical benefit. Several intervention initiatives have been taken to
reduce the inappropriate use of antibiotics in primary health care, but the effectiveness of these interventions is only
modest. Only few studies have been designed to determine the effectiveness of multifaceted strategies in countries
with different practice setting. The aim of this study is to evaluate the impact of a multifaceted intervention targeting
general practitioners (GPs) and patients in six countries with different prevalence of antibiotic resistance: Two Nordic
countries (Denmark and Sweden), two Baltic Countries (Lithuania and Kaliningrad-Russia) and two Hispano-
American countries (Spain and Argentina).
Methods/Design: HAPPY AUDIT was initiated in 2008 and the project is still ongoing. The project includes 15 partners 
from 9 countries. GPs participating in HAPPY AUDIT will be audited by the Audit Project Odense (APO) method. The 
APO method will be used at a multinational level involving GPs from six countries with different cultural background 
and different organisation of primary health care. Research on the effect of the intervention will be performed by 
analysing audit registrations carried out before and after the intervention. The intervention includes training courses 
on management of RTIs, dissemination of clinical guidelines with recommendations for diagnosis and treatment, 
posters for the waiting room, brochures to patients and implementation of point of care tests (Strep A and CRP) to be 
used in the GPs'surgeries.
To ensure public awareness of the risk of resistant bacteria, media campaigns targeting both professionals and the
public will be developed and the results will be published and widely disseminated at a Working Conference hosted
by the World Association of Family Doctors (WONCA-Europe) at the end of the project period.
Discussion: HAPPY AUDIT is an EU-financed project with the aim of contributing to the battle against antibiotic 
resistance through quality improvement of GPs' diagnosis and treatment of RTIs through development of intervention 
programmes targeting GPs, parents of young children and healthy adults. It is hypothesized that the use of 
multifaceted strategies combining active intervention by GPs will be effective in reducing prescribing of unnecessary 
antibiotics for RTIs and improving the use of appropriate antibiotics in suspected bacterial infections.BioMed Central
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Excessive and inappropriate use of antibiotics is consid-
ered to be the most important reason for development of
bacterial resistance to antibiotics [1-3]. Countries with a
high use of antibiotics like the Southern European coun-
tries have a high rate of resistance, while the Nordic
countries with a low use have a low resistance rate [4]. As
antibiotic resistance may spread across borders, high
prevalence countries may serve as a source of bacterial
resistance for countries with a low prevalence. Therefore,
bacterial resistance is an important issue with a poten-
tially serious impact on all countries.
Infections caused by resistant bacteria lead to an
increased mortality, prolonged hospital stay and
increased costs [5,6]. History has told us that this prob-
lem will not be solved by the provision of more potent
antibiotics by the pharmaceutical industry - quite the
contrary. The control of antibiotic resistance should be
solved by other initiatives. A cornerstone of efforts to
control antibiotic resistance is to improve the quality of
antibiotic prescribing in primary health care, as more
than 90% of antibiotics are prescribed by GPs. The major-
ity of antibiotics prescribed in general practice are for
respiratory tract infections (RTIs) which constitute
approximately 70% of all infections treated in family prac-
tice [7,8]. The majority of RTIs (90%) are caused by virus
and in these cases antibiotics are unlikely to have any
clinical benefit for the patient. Most RTIs are harmless
and self-limiting and nearly all patients recover without
any specific treatment. Antibiotic treatment may thus be
superfluous, and in some cases it may be directly harmful
due to adverse effects. Even if the aetiology is bacterial,
antibiotics modify RTIs only slightly, particular in
patients with upper RTIs [9,10].
Previous research
It has been clearly documented that the prevalence of
resistant strains is correlated with the consumption of
antibiotics, and studies comparing bacterial resistance in
various European countries have shown striking differ-
ences in the consumption of antibiotics [4,11]. Until
recently, the rates of antibiotic resistance in the northern
European countries have remained low. However, the
rates of resistance in the southern European countries are
reaching alarming levels.
Studies of the management of RTIs show that a consid-
erable number of antibiotic prescriptions are neither nec-
essary nor appropriate [12,13]. Studies from general
practice have shown that more than half of all patients
with colds and respiratory tract infections (RTIs) and
about nine out of ten patients with suspected bronchitis
are treated with antibiotics. The different antibiotic pre-
scribing rates between countries cannot be explained by
different frequency or patterns of RTIs. More likely, it is
due to discrepancies in national recommendations, dif-
ferent health care systems, different treatment traditions,
different culture, different patient expectations or differ-
ent impact of marketing by pharmacies and pharmaceuti-
cal companies.
Several initiatives have been taken to reduce the inap-
propriate use of antibiotics in primary health care. How-
ever, most interventions have not achieved impressive
results [14]. Printed educational material and didactic
lectures only have little influence on prescribing habits.
According to a review from the Cochrane Library, multi-
faceted interventions seem to be more effective than sin-
gular interventions [14]. However, only a few
multifaceted interventions targeting treatment of RTIs
have been performed.
Most studies investigating consumption of antibiotics
in different countries have been based on aggregated data
from prescription databases or from wholesale figures.
Such data do generally not contain information about the
indication for prescription. As the vast majority of antibi-
otic prescriptions in general practice are issued for RTIs,
studies comparing GPs' management of different RTIs are
suitable for exploring the consumption of antibiotics in
more detail. Particularly, information about the back-
ground for prescribing in countries with different preva-
lence of antibiotic resistance is needed.
Only few studies have been designed to evaluate and
compare the effect of multifaceted interventions in coun-
tries with different practice settings. Furthermore, we
need more knowledge about the effect of combining
interventions. Particularly, we need information about
factors that may influence the effect of interventions tar-
geting doctors and patients from different practice set-
tings.
The aim of this study is to evaluate the impact of a mul-
tifaceted intervention including an active intervention by
GPs on their antibiotic prescribing in six countries with
different prevalence of antibiotic resistance: Two Nordic
countries (Denmark and Sweden), two Baltic Countries
(Lithuania and Kaliningrad-Russia) and two Hispano-
American countries (Spain and Argentina).
Methods/Design
HAPPY AUDIT was initiated in 2008 and the project is
still ongoing; it is planned to be finalized by the end of
2010. The project includes 15 partners from 9 countries,
as indicated in Table 1.
The proposed method for auditing GPs participating in
HAPPY AUDIT is called Audit Project Odense (APO)
[15]. APO has been developed and successfully tested
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[16].
In this project APO will be used at a multinational level
involving GPs from six countries with different cultural
background and different organisation of primary health
care. Research on the effect will be performed by
analysing audit registrations carried out before and after
the intervention period. Recommendations for health
policy at political level will be prepared. The results will
be widely disseminated at a Working Conference at the
end of the project period.
HAPPY AUDIT is structured into 12 work packages
(WPs) and organized in 3 groups as indicated in Figure 1.
1. Research on existing behavioural tools: APO cycles
• Planning of Audit cycles (WP2)
• Development of quality indicators (WP3)
• Preparation of intervention materials for patients
(WP4) and professionals (WP5)
2. Implementation of APO cycles (WP6, WP7, WP8
and WP9)
• Initial registration of patients with RTIs (before
intervention)
• Intervention activities targeted professionals and
patients
• Final registration of patients with RTIs (after inter-
vention)
3. Developing tools for development, implementation
and evaluation of media campaigns
• Analyzing the effect of the intervention (WP10)
• Working Conference with presentation of recom-
mendations from the study (WP11)
• Preparing for media campaigns at national level
(WP12)
After completion of WP2-WP5, the initial APO regis-
tration will take place. The audit cycles are performed in
six countries with contrasting prevalence of antibiotic
resistance: two countries with low consumption of antibi-
otics and low resistance rates (Sweden and Denmark),
two countries with high consumption of antibiotics and
high resistance rates (Spain and Argentina), and two
countries with an increasing consumption of antibiotics
and increasing resistance rates (Lithuania and Russia).
According to the APO method, patients will be regis-
tered using a prospective self-registry methodology based
on a simple chart completed by the GP during the consul-
tation (Figure 2).
A report will be prepared and subsequently discussed
at the first follow-up meting during the intervention
phase. The participants will discuss their own perfor-
mance, identify quality problems and consider possible
barriers and solutions to elimination of the quality prob-
lems.
Each GP will register patients during a 3-week period
before and after the intervention.
The minimum number of GPs per audit cycle has been
estimated based on the following assumptions: Each GP
will register about 25 consultations during the 3 weeks of
audit registration. A decrease of 10% in antibiotic pre-
scribing can be expected after the intervention (from
about 40% before to about 30% after). The within-prac-
tice correlation coefficient is 0.1.
If the comparison is to be performed at the 5% level of
significance (two-sided) with 80% power, then the num-
ber of GPs to be included should be 48 per APO cycle.
Intervention
The follow-up intervention activities will comprise work-
shops, clinical skills courses, reminders and clinical train-
ing, as well as interdisciplinary training courses (Figure
3). The intervention also includes introduction of diag-
nostic classification of patients with RTIs by using micro-
biological laboratory point of care (POC) tests:
Streptococcus Antigen test (Strep A) and C-reactive Pro-
tein test (CRP).
After the first registration, the GPs will receive personal
feedback based on individual data on results from the
first registration. Furthermore, they will receive feedback
from the group of GPs in their country based on aggre-
gated data on results from the first registration. The
results will be discussed at follow-up meetings, and
Table 1: Partners in HAPPY AUDIT
Participant organisation name
Research Unit of General Practice, University of Southern 
Denmark
General Practice Consultants, Odense, Denmark
Ministry of the Interior and Health, Denmark
Department of Clinical Sciences, Lund University, Sweden
National Board of Health and Welfare, Sweden
Family Doctor (FD) Centre, Lithuania
State Patient Fund; Lithuania
Association of Family Doctors, Kaliningrad, Russia
Spanish Society of Family Medicine, Spain
University of Las Palmas de Gran Canarias, Spain
Consejería de Sanidad del Gobierno de Canarias, Spain
Misiones Association of General Family Medicine, Posadas, 
Argentina
World Health Organisation, Collaborating Centre for Drug 
Statistics Methodology, Oslo, Norway
World Organisation of Family Doctors (WONCA), Slovenia
European Drug Utilisation Research Group, Belgium
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activities initiated. The intervention will start after the
first registration period and it will include the following
activities:
• Training course on appropriate use of antibiotics for
RTIs
• Clinical guidelines including recommendations for
diagnosis and treatment of RTIs
• Posters for doctors' waiting rooms, focusing on the
appropriate use of antibiotics, and targeting all patients
visiting practice
• Brochures and handouts to patients about prudent
use of antibiotics
• Point of care (POC) rapid tests: Strep A and CRP
• Training in use and interpretation of results from
POC rapid tests
After the intervention period, the GPs will perform the
second registration during a 3-week period one year later.
In order to evaluate the influence of specific elements
of the intervention (e.g. introduction of POC tests) GPs
will be exposed to different types and combinations of
intervention activities during the study. The majority of
GPs will be exposed to prescription feedback, guidelines,
courses and POC tests. A group of GPs will only be
offered prescription feedback and guidelines, but no POC
test. Another group of GPs will not be exposed to any
type of intervention activities, except performance of an
audit cycle (control group).
Figure 1 HAPPY AUDIT structure.
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The statistical analysis will provide an understanding of
the effect of intervention. GPs' prescribing of antibiotics
for patients with RTIs will be compared in countries with
high prevalence of antibiotic resistance among respira-
tory pathogens (Hispano-America and the Baltic Coun-
tries) and countries with low prevalence of antibiotic
resistance (Denmark, Sweden).
The ecological fallacy introduced by using aggregated
data may mislead strategies to combat antibiotic resis-
tance. Analyses of data of individual patients are there-
fore essential to direct policies in strategies to combat
antibiotic resistance. The method proposed for the analy-
sis is a multilevel model to determine how the clinical
prescription practice has changed after the intervention.
The sample selection of physicians, the inclusion criteria
and recruitment mechanism will be designed to get as
good statistical information as possible with the data
coming from a natural hierarchy of units grouped at dif-
ferent levels:
• The type of RTI in patients
• The GPs
• The organisation of primary health care in different
regions or countries
The aim of multilevel models in HAPPY AUDIT is to
analyse the results of the audit (comparing before and
after the audit) with regard to a number of dependent
variables: appropriateness of antibiotic prescriptions
(multilevel discrete choice models); number and rate of
Figure 2 The HAPPY AUDIT registration sheet.
GP
________________
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
1
2
3
4
5
6
7
8
9
10
11
12
Audit on respiratory tract infections
Registration date:
28 29 30 31 32
Only 1 x
DiagnosisTests Antibiotics
®Copyright: Audit Projekt Odense, J.B. Winsløws Vej 9A, 1. 5000 Odense C
Sex
Age
M F
Etiolo-
gy 
Minimum 1 x
33 34 35 36 37 38 39
Symptoms and signs
1 x
40 41
Others
42
Days
Minimum 1 x Minimum 1 x Minimum 1 x
Figure 3 The Audit project Odense method.
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Page 6 of 7antibiotic prescriptions, expenditure and others. These
models allow us to test if there are environmental and
organisational factors influencing the effectiveness of the
audit (Are there any significant differences among
regions? Are there some characteristics of the GPs influ-
encing the audit results?)
The data will be analyzed by the statistical program
Stata, version 11. The chi-squared, Student's t tests, and
analysis of variance will be used to compare proportions
and means, respectively. Multilevel logistic regression
analyses will be performed to evaluate the effect of the
intervention at different levels. Statistical significance will
be considered with a p value < 0.05.
Limitations of the study
GPs participate on a voluntary basis and probably their
prescribing habits may not represent the average use of
antibiotics in their country [17]. GPs participating in
audits may be more interested in quality development
and research than GPs in general. Furthermore, they are
willing to dedicate time to complete audit reports without
economic incentives.
The amount of time involved in a quality improvement
project could be considered to be a prominent barrier to
participation, as GPs may find it difficult to find the time
in their daily work. However, participation in an APO
registration is not very time-consuming. Each registra-
tion takes less than 2 minutes. But the GPs need to set
aside time for the subsequent courses or other activities
planned in the intervention.
Another limitation which should be taken into account
is the fact that performing an audit may in itself influence
the prescribing habits. However, studies have shown that
the reliability of the Audit Project Odense methodology
applied in different countries is high and findings are cor-
related with the real prescription in practice [15].
From a theoretical point of view, the decision to treat
should be taken after a diagnosis has been established. In
general practice, however, the diagnostic procedures and
the decision to treat are intricately linked. The GP may
decide whether or not to prescribe an antibiotic at the
same time, or even before, he classifies a specific diagno-
sis to the patient. After making the decision to prescribe
the GP may thus adjust the diagnosis to fit the decision
about treatment. This may lead to a diagnostic misclassi-
fication bias. However, this potential bias will affect the
validity of the diagnosis both before and after the inter-
vention and it only has a small likelihood of influencing
the effect of the intervention.
Due to the limited time allocated for the registration
process in practice only the typical signs and symptoms
for RTIs according to the medical literature will be
recorded. This may lead to some limitations. Non-bio-
medical factors that may represent very powerful predic-
tors of antibiotic prescription will not be taken into
account in this study.
The before-after design used in this study suffers from
some limitations due to the fact that changes in antibiotic
prescribing could be due to other factors than the inter-
vention performed by the investigators.
Ethical considerations
All patient registration data will be treated confidentially
according to the law on protection of sensitive data. The
data will be organised in a database and made available
for analysis in this project and for research in future proj-
ects. The project will be conducted in accordance with
the EU Directive of good clinical practice (EU Directive
2001/20/EC).
During the APO cycle, the participating GPs will be
exposed to different interventions, but patients will not
undergo any intervention. Therefore, patients will not be
asked for informed consent. Patients will be informed
about the objective of the project and they will be told
that specific clinical information related to the consulta-
tion will be entered into a multinational database. Appro-
priate protection of patient information is paramount and
all data from the project will be processed according to
the European Community Data Protection Directive (EU-
Directive 95/46/EC) on the protection of individuals with
regard to the processing of personal data.
Patients will be registered by age and sex only. No elec-
tronic patient identifier (such as civil registration num-
ber) will be used, and there will be no information that
can be used to identify individual registry patients by per-
sonal analysis of the data. The identity of the participat-
ing GPs will be considered to be confidential information.
All personnel with access to data containing personal
identifiers will sign a pledge to maintain the confidential-
ity of study subjects. All data management and statistical
analysis programs used in the analyses will be docu-
mented.
Approval has been obtained from the Ethical Commit-
tees of Investigation in Primary Care in the six participat-
ing countries.
Discussion
Despite the exaggerated use of antibiotics and the grow-
ing development of bacterial resistance, only few initia-
tives have been taken to reduce the inappropriate use of
antibiotics. The aim of the HAPPY AUDIT study is to
evaluate the impact of a multifaceted intervention pro-
gramme focusing on appropriate treatment of RTIs and
targeting general practitioners and patients in general
practice.
The study takes place in six countries with contrasting
prevalence of antibiotic resistance. The intervention will
combine a number of intervention initiatives, including
Bjerrum et al. BMC Family Practice 2010, 11:29
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Page 7 of 7feedback to GPs, training courses, follow-up meetings,
guidelines, posters for waiting rooms, brochures to the
patients, and implementation of POC tests (Strep A and
CRP) in practice.
The APO cycles in this study will be performed in a
natural practice setting, and patients will not be informed
about the project prior to the consultations. GPs partici-
pating in the audit will not get allocated extra time for
consultations, and they will not be able to make consider-
able changes in their practice activities during the 3
weeks of registration. Thus, they will see the same
patients as if they were not participating in the audit.
Therefore, it is most likely that the results from the
project can be extrapolated to other areas and used to
influence other practices with similar settings.
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